Literature DB >> 25061169

Platelets as pivot in the antiphospholipid syndrome.

Philip G de Groot1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25061169      PMCID： PMC4110653          DOI： 10.1182/blood-2014-06-576983

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

Review 1.  Mechanisms of monocyte recruitment in vascular repair after injury.

Authors:  Andreas Schober; Christian Weber
Journal:  Antioxid Redox Signal       Date:  2005 Sep-Oct       Impact factor: 8.401

Review 2.  The pathogenesis of the antiphospholipid syndrome.

Authors:  Bill Giannakopoulos; Steven A Krilis
Journal:  N Engl J Med       Date:  2013-03-14       Impact factor: 91.245

3.  Presence of lipocortins I and IV, but not II and VI, in human platelets.

Authors:  J A Eldering; M Kocher; J M Clemetson; K J Clemetson; F J Frey; B M Frey
Journal:  FEBS Lett       Date:  1993-03-08       Impact factor: 4.124

4.  Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome.

Authors:  Zurina Romay-Penabad; Renan Aguilar-Valenzuela; Rolf T Urbanus; Ronald H W M Derksen; Maarten T T Pennings; Elizabeth Papalardo; Tuya Shilagard; Gracie Vargas; Yong Hwang; Philip G de Groot; Silvia S Pierangeli
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

Review 5.  β(2) -Glycoprotein I: evolution, structure and function.

Authors:  P G de Groot; J C M Meijers
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

6.  Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.

Authors:  Cetin Agar; Gwendolyn M A van Os; Matthias Mörgelin; Richard R Sprenger; J Arnoud Marquart; Rolf T Urbanus; Ronald H W M Derksen; Joost C M Meijers; Philip G de Groot
Journal:  Blood       Date:  2010-05-12       Impact factor: 22.113

7.  Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.

Authors:  Valerie Proulle; Richard A Furie; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Blood       Date:  2014-05-13       Impact factor: 22.113
  7 in total
  4 in total

1.  Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies.

Authors:  Nadine Müller-Calleja; Svenja Ritter; Anne Hollerbach; Tanja Falter; Karl J Lackner; Wolfram Ruf
Journal:  Blood Adv       Date:  2018-05-08

2.  Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome.

Authors:  Dolores Pérez; Ljudmila Stojanovich; Laura Naranjo; Natasa Stanisavljevic; Gordana Bogdanovic; Manuel Serrano; Antonio Serrano
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

3.  Thrombocytopenia in a cohort of primary and secondary antiphospholipid syndrome patients: Relation to clinical, laboratory manifestations and damage index.

Authors:  Sherif Gamal; Samar Mohamed; Abdelkawy Moghazy
Journal:  Arch Rheumatol       Date:  2022-01-23       Impact factor: 1.007

4.  Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome.

Authors:  Laura Naranjo; Ljudmila Stojanovich; Aleksandra Djokovic; Laura Andreoli; Angela Tincani; Maria Maślińska; Savino Sciascia; Maria Infantino; Sara Garcinuño; Kinga Kostyra-Grabczak; Mariangela Manfredi; Francesca Regola; Natasa Stanisavljevic; Milomir Milanovic; Jovica Saponjski; Dario Roccatello; Irene Cecchi; Massimo Radin; Maurizio Benucci; Daniel Pleguezuelo; Manuel Serrano; Yehuda Shoenfeld; Antonio Serrano
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.